EP Patent

EP1000615A2 — Preparation of pharmaceutically active particles

Assigned to Kenvue Brands LLC · Expires 2000-05-17 · 26y expired

What this patent protects

The present invention provides a core of predominately microcrystalline cellulose, on which an active drug is layered onto the core via solution coating. The coated particles have a narrower particle size distribution than coated granules provided by other processes. An optional …

USPTO Abstract

The present invention provides a core of predominately microcrystalline cellulose, on which an active drug is layered onto the core via solution coating. The coated particles have a narrower particle size distribution than coated granules provided by other processes. An optional final coating of a pharmaceutically acceptable polymeric coating is provided to provide tastemaking or controlled release, and protection of the drug-layered particles.

Drugs covered by this patent

Patent Metadata

Patent number
EP1000615A2
Jurisdiction
EP
Classification
—
Expires
2000-05-17
Drug substance claim
No
Drug product claim
No
Assignee
Kenvue Brands LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.